{
    "eid": "2-s2.0-85112058234",
    "title": "A single-cycle influenza a virus-based sars-cov-2 vaccine elicits potent immune responses in a mouse model",
    "cover-date": "2021-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "SARS-CoV-2",
        "Single-cycle influenza virus-based vaccine",
        "Spike RBD",
        "Spike-pseudotyped virus"
    ],
    "authors": [
        "Surapong Koonpaew",
        "Challika Kaewborisuth",
        "Kanjana Srisutthisamphan",
        "Asawin Wanitchang",
        "Theeradej Thaweerattanasinp",
        "Janya Saenboonrueng",
        "Sukontip Poonsuk",
        "Juggragarn Jengarn",
        "Ratchanont Viriyakitkosol",
        "Jarin Kramyu",
        "Anan Jongkaewwattana"
    ],
    "citedby-count": 18,
    "ref-count": 30,
    "ref-list": [
        "COVID-19 Vaccines: Modes of Immune Activation and Future Challenges",
        "COVID-19 Commission of Accademia Nazionale dei Lincei, Rome. COVID-19 Vaccines: Where We Stand and Challenges Ahead",
        "Unidirectional RNA Polymerase I-Polymerase II Transcription System for the Generation of Influenza A Virus from Eight Plasmids",
        "A Recombinant Influenza A Virus Expressing Domain III of West Nile Virus Induces Protective Immune Responses against Influenza and West Nile Virus",
        "Chimeric Influenza Virus Hemagglutinin Proteins Containing Large Domains of the Bacillus Anthracis Protective Antigen: Protein Characterization, Incorporation into Infectious Influenza Viruses, and Antigenicity",
        "Mucosal Model of Immunization against Human Immunodeficiency Virus Type 1 with a Chimeric Influenza Virus",
        "Intranasal Vaccination with an Engineered Influenza Virus Expressing the Receptor Binding Subdomain of Botulinum Neurotoxin Provides Protective Immunity against Botulism and Influenza",
        "Replication-Defective Viruses as Vaccines and Vaccine Vectors",
        "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein",
        "Immunogenicity of a DNA Vaccine Candidate for COVID-19",
        "Trials in Man with Live Recombinants Made from A/PR/8/34 (H0 N1) and Wild H3 N2 Influenza Viruses",
        "Influenza B Virus M2 Protein Can Functionally Replace Its Influenza A Virus Counterpart in Promoting Virus Replication",
        "Type III IFN Interleukin-28 Mediates the Antitumor Efficacy of Oncolytic Virus VSV in Immune-Competent Mouse Models of Cancer",
        "Identification of a Novel Splice Variant Form of the Influenza A Virus M2 Ion Channel with an Antigenically Distinct Ectodomain",
        "A DNA Transfection System for Generation of Influenza A Virus from Eight Plasmids",
        "Universal Primer Set for the Full-Length Amplification of All Influenza A Viruses",
        "A simple method of estimating fifty per cent endpoints",
        "Class I MHC Molecules Rather than Other Mouse Genes Dictate Influenza Epitope Recognition by Cytotoxic T Cells",
        "Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis",
        "Tissue Plasminogen Activator (TPA) Signal Sequence Enhances Immunogenicity of MVA-Based Vaccine against Tuberculosis",
        "Influenza a Virus M2 Ion Channel Activity Is Essential for Efficient Replication in Tissue Culture",
        "Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology",
        "Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs",
        "Exploitation of Nucleic Acid Packaging Signals to Generate a Novel Influenza Virus-Based Vector Stably Expressing Two Foreign Genes",
        "Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment",
        "Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19",
        "Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity",
        "Impact of Preexisting Vector-Specific Immunity on Vaccine Potency: Characterization of Listeria Monocytogenes-Specific Humoral and Cellular Immunity in Humans and Modeling Studies Using Recombinant Vaccines in Mice",
        "Pre-Existing Immunity against Ad Vectors: Humoral, Cellular, and Innate Response, What\u2019s Important?",
        "Effects of Pre-Existing Orthopoxvirus-Specific Immunity on the Performance of Modified Vaccinia Virus Ankara-Based Influenza Vaccines"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60011947",
            "affilname": "Thailand National Center for Genetic Engineering and Biotechnology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011947",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Vaccine Institute",
        "Research Development Innovation Management",
        "National Science and Technology Development Agency"
    ]
}